Primary Site >> Stomach Cancer

Gene >> TEAD4

  • 2014
  • 2016
  • 2017
  • 2018
Ref: Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer.
PMID: 24325916
Ref: Nuclear localization of TEF3-1 promotes cell cycle progression and angiogenesis in cancer.
PMID: 26885617
Ref: RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
PMID: 27425596
Ref: DNA-binding mechanism of the Hippo pathway transcription factor TEAD4.
PMID: 28368398
Ref: TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
PMID: 28759040
Ref: Targeting IRF3 as a YAP agonist therapy against gastric cancer.
PMID: 29339449
Ref: miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
PMID: 29367737
Ref: Epigenetic silencing of miR-1271 enhances MEK1 and TEAD4 expression in gastric cancer.
PMID: 29862663
Ref: Computational insights into the interaction mechanism of transcription cofactor vestigial-like protein 4 (VGLL4) binding to TEA domain transcription factor 4 (TEAD4) by molecular dynamics simulation and molecular mechanics generalized Born/surface area (M
PMID: 30051771